CRESSEY & COMPANY LP
CRESSEY & COMPANY LP is a Series C+ and buyout fund in the US writing $10M–$100M checks into healthcare-tech and healthcare-services.
- Stages
- Series C+, buyout
- Sectors
- healthcare-tech, healthcare-services
- Check size
- $10M–$100M
- Invests in
- US-wide
- Actively investing
- Yes
- Founded
- 2008
- Assets under management
- $3.55B
- Website
- cresseyco.com
Thesis
Cressey & Company LP is a private equity firm with over 40 years of experience, exclusively focused on the healthcare sector. They employ a 'Target, Partner, Build' strategy, identifying high-potential healthcare segments and partnering with leading companies to foster growth and innovation. Their primary targets are middle-market companies in healthcare services and healthcare technology, including providers, facilities, IT, specialty care management, and cardiovascular disease. Cressey & Company engages in various investment types such as expansion, later-stage ventures, MBOs, LBOs, and control/minority equity investments, often taking board seats. The firm manages significant capital, with AUM around $3.55 billion as of March 2026. Their typical check size ranges from $10 million to $75 million, with a maximum of $100 million. They generally target companies with enterprise values between $25 million and $150 million, sometimes up to $500 million. The firm operates primarily within the United States and was founded in 2008, with headquarters in Chicago, Illinois.
Common questions
Does CRESSEY & COMPANY LP invest at the Series C+ stage?
Yes. CRESSEY & COMPANY LP lists Series C+ and buyout among the stages it invests in.
What check size does CRESSEY & COMPANY LP write?
CRESSEY & COMPANY LP writes $10M–$100M checks.
Where does CRESSEY & COMPANY LP invest?
CRESSEY & COMPANY LP invests in the US.